These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 24520866)
1. Self-assembled liquid crystalline nanoparticles as an ophthalmic drug delivery system. Part II: optimization of formulation variables using experimental design. Achouri D; Sergent M; Tonetto A; Piccerelle P; Andrieu V; Hornebecq V Drug Dev Ind Pharm; 2015 Mar; 41(3):493-501. PubMed ID: 24520866 [TBL] [Abstract][Full Text] [Related]
2. Self-assembled liquid crystalline nanoparticles as an ophthalmic drug delivery system. Part I: influence of process parameters on their preparation studied by experimental design. Achouri D; Hornebecq V; Piccerelle P; Andrieu V; Sergent M Drug Dev Ind Pharm; 2015 Jan; 41(1):109-15. PubMed ID: 24188327 [TBL] [Abstract][Full Text] [Related]
3. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability. Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263 [TBL] [Abstract][Full Text] [Related]
5. Cubic liquid crystalline nanoparticles: optimization and evaluation for ocular delivery of tropicamide. Verma P; Ahuja M Drug Deliv; 2016 Oct; 23(8):3043-3054. PubMed ID: 26878398 [TBL] [Abstract][Full Text] [Related]
6. A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate. Li J; Wu L; Wu W; Wang B; Wang Z; Xin H; Xu Q Int J Pharm; 2013 Oct; 455(1-2):75-84. PubMed ID: 23916822 [TBL] [Abstract][Full Text] [Related]
7. Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo Evaluation. Liu R; Wang S; Fang S; Wang J; Chen J; Huang X; He X; Liu C Nanoscale Res Lett; 2016 Dec; 11(1):254. PubMed ID: 27188974 [TBL] [Abstract][Full Text] [Related]
8. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM). Rizwan SB; Dong YD; Boyd BJ; Rades T; Hook S Micron; 2007; 38(5):478-85. PubMed ID: 17011783 [TBL] [Abstract][Full Text] [Related]
9. An injectable liquid crystal system for sustained delivery of entecavir. Lim JL; Ki MH; Joo MK; An SW; Hwang KM; Park ES Int J Pharm; 2015 Jul; 490(1-2):265-72. PubMed ID: 26004002 [TBL] [Abstract][Full Text] [Related]
10. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz. Avachat AM; Parpani SS Colloids Surf B Biointerfaces; 2015 Feb; 126():87-97. PubMed ID: 25543986 [TBL] [Abstract][Full Text] [Related]
11. Freeze-dried and re-hydrated liquid crystalline nanoparticles stabilized with disaccharides for drug-delivery of the plectasin derivative AP114 antimicrobial peptide. Boge L; Västberg A; Umerska A; Bysell H; Eriksson J; Edwards K; Millqvist-Fureby A; Andersson M J Colloid Interface Sci; 2018 Jul; 522():126-135. PubMed ID: 29587194 [TBL] [Abstract][Full Text] [Related]
12. Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation. Chen Y; Lu Y; Zhong Y; Wang Q; Wu W; Gao S J Drug Target; 2012 Dec; 20(10):856-63. PubMed ID: 23050903 [TBL] [Abstract][Full Text] [Related]
13. Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles. Castro GA; Coelho AL; Oliveira CA; Mahecha GA; Oréfice RL; Ferreira LA Int J Pharm; 2009 Oct; 381(1):77-83. PubMed ID: 19647057 [TBL] [Abstract][Full Text] [Related]
14. Formulation and characterization of a liquid crystalline hexagonal mesophase region of phosphatidylcholine, sorbitan monooleate, and tocopherol acetate for sustained delivery of leuprolide acetate. Báez-Santos YM; Otte A; Mun EA; Soh BK; Song CG; Lee YN; Park K Int J Pharm; 2016 Nov; 514(1):314-321. PubMed ID: 27863678 [TBL] [Abstract][Full Text] [Related]
15. Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential. Singh B; Khurana L; Bandyopadhyay S; Kapil R; Katare OO Drug Deliv; 2011 Nov; 18(8):599-612. PubMed ID: 22008038 [TBL] [Abstract][Full Text] [Related]
16. Predicting the complex phase behavior of self-assembling drug delivery nanoparticles. Le TC; Mulet X; Burden FR; Winkler DA Mol Pharm; 2013 Apr; 10(4):1368-77. PubMed ID: 23464802 [TBL] [Abstract][Full Text] [Related]
18. Characterization of bupivacaine-loaded formulations based on liquid crystalline phases and microemulsions: the effect of lipid composition. Yaghmur A; Rappolt M; Østergaard J; Larsen C; Larsen SW Langmuir; 2012 Feb; 28(5):2881-9. PubMed ID: 22247936 [TBL] [Abstract][Full Text] [Related]
19. Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies. Shah M; Chuttani K; Mishra AK; Pathak K Drug Dev Ind Pharm; 2011 May; 37(5):526-37. PubMed ID: 21128704 [TBL] [Abstract][Full Text] [Related]
20. Nebulized oil-in-water nanoemulsion mists for pulmonary delivery: development, physico-chemical characterization and in vitro evaluation. Nesamony J; Shah IS; Kalra A; Jung R Drug Dev Ind Pharm; 2014 Sep; 40(9):1253-63. PubMed ID: 23837519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]